A:NYSE, Agilent Technologies, Inc.

A stock overview

Agilent Technologies, Inc. (A:NYSE) closed at $175.54 on October 15, 2026, up 0.89% on the day. The stock trades 0.9% below its 52-week high of $177.05 and 62.0% above its 52-week low of $108.35. Over the past year, it gained 24.6%. Agilent Technologies, Inc. is part of the Capital Goods sector (Biotechnology: Laboratory Analytical Instruments).

Key figures

Price
$175.54
Day change
+0.89%
Volume
1,256,446
Average volume
2,258,868
Market cap
49B+
52-week range
$108.35 – $177.05
50-day average
$157.57
200-day average
$134.14

Performance

5D 1M 3M 6M 1Y
+1.56% +15.79% +32.36% +43.85% +24.60%

Price action over the past year

In 252 trading sessions since October 14, 2025, A closed higher on 130 days (52%). Its best day was May 28, 2026 (+16.87%) and its worst was April 23, 2026 (-5.02%). The stock moved 10% or more in a single session 1 time. It opened at least 5% above the previous day's high 1 time.

Recent signals

A news

About Agilent Technologies, Inc.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. Its Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The company's Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment services; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. Its A...

Similar stocks

Find more stocks like A with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.